Webinar: Shifting Cannabis Science from Botany to Neuroscience: From Bud to Brain
In a sweeping overview of cannabis science, Dr. Cermak integrates bench research into practical treatment. He condenses basic science about the brain’s Endocannabinoid System (ECS), explains how too frequent cannabis impacts the ECS to cause measurable cognitive and emotional changes, and then provides tips on how this information can be used to develop meaningful conversations with cannabis users. Webinar participants will understand how basic science connects to clinically relevant signs and symptoms and how the art of treatment can use science-based motivational interviewing to explore the values underlying cannabis use.
Identify early warning signs of cannabis overuse;
Describe the endocannabinoid system and the impact of cannabis overuse; and
Select appropriate opportunities to utilize motivational interviewing to discuss cannabis use with patients.
Dr. Timmen L. Cermak majored in philosophy at Ohio Wesleyan, graduated from Case Western Reserve Medical School in 1972 and completed psychiatric residency and a post-doctoral fellowship in neurophysiology at Stanford. He co-founded the National Association for Children of Alcoholics in 1982, is a Past-President of the California Society of Addiction Medicine and chaired the CSAM Task Force on Marijuana Policy. Dr. Cermak chaired the Youth Work Group for Lt. Governor Gavin Newsom’s Blue-Ribbon Commission on Marijuana Policy and served on the Bureau of Cannabis Control’s Cannabis Advisory Committee, where he chaired the Public Health/Youth Subcommittee. He published Marijuana: What’s a Parent to Believe? with Hazelden in 2003 and From Bud to Brain: A Psychiatrist’s View of Marijuana was released in April 2020 by Cambridge University Press to provide basic science information about cannabis to healthcare professionals and educators. A book for the general public, also from Cambridge, titled Marijuana on My Mind: The Science and Mystique of Cannabis, was released on 4-20-22. Dr. Cermak retired from his private practice of psychiatry and addiction medicine in early 2021.
DISCLOSURE STATEMENT OR INFORMATION
In accordance with CSAM and CMA policies, all planners, faculty, and moderators with control over activity content are required to disclose any financial relationships held with ineligible companies over the last 24 months.
Tim Cermack, MD - No relevant disclosures
Mason Turner, MD, DFASAM; Spencer Hansen, MD; Amy de la Garza, MD - No relevant disclosures
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this educational activity/enduring material for a maximum of 1 AMA/PRA Category 1 Credits™.
NON-PHYSICIANS: The California Society of Addiction Medicine (CSAM) provides a certificate of attendance for this online course.
- 1.00 AMA Category 1